Aeglea BioTherapeutics, Inc. (AGLE) Stock Dipping in Early Trading, Here’s the Reason.
Maria Masood
February 10, 2022
Aeglea BioTherapeutics, Inc. (AGLE) is a clinical-stage biopharmaceutical company engaged in developing human enzyme therapeutics to treat rare metabolic disease patients. One of the lead